A Semi-Mechanistic Integrated Pharmacokinetic/Pharmacodynamic Model of the Testosterone Effects of the Gonadotropin-Releasing Hormone Agonist Leuprolide in Prostate Cancer Patients-Reference-Cited by-同舟云学术

A Semi-Mechanistic Integrated Pharmacokinetic/Pharmacodynamic Model of the Testosterone Effects of the Gonadotropin-Releasing Hormone Agonist Leuprolide in Prostate Cancer Patients

Published:2015-03-20 Issue:9 Volume:54 Page:963-973
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Lim Chay Ngee,Salem Ahmed Hamed

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40262-015-0251-9.pdf

Reference39 articles.

1. American Cancer Society. What are the key statistics about prostate cancer? 2014. http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistics . Accessed 8 Nov 2014.

2. National Cancer Institute. Prostate cancer treatment (PDQ®). 2014. http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page7 . Accessed 8 Nov 2014.

3. Saylor PJ, Smith MR. Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer. J Natl Compr Canc Netw. 2010;8:211–23.

4. Trachtenberg J. Hormonal management of stage D carcinoma of the prostate. In: Carson CC, editor. Problems in urology, vol. 7. Philadelphia: JB Lippincott Co; 1993. p. 215–25.

5. Perrin MH, Rivier JE, Vale WW. Radioligand assay for gonadotropin-releasing hormone: relative potencies of agonists and antagonists. Endocrinology. 1980;106:1289–93.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerating Digitalization in Healthcare with the InSilicoTrials Cloud-Based Platform: Four Use Cases;Annals of Biomedical Engineering;2022-09-08

2. CHST7 Methylation Status Related to the Proliferation and Differentiation of Pituitary Adenomas;Cells;2022-08-04

3. Mathematical model of hormone sensitive prostate cancer treatment using leuprolide: A small step towards personalization;PLOS ONE;2022-02-15

4. Preclinical PK/PD model for the combinatorial use of dexamethasone and sulpiride in the treatment of breast cancer;Acta Pharmacologica Sinica;2019-06-05

5. Pharmacokinetic–Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats;Molecules;2018-04-15